Allogene Therapeutics Inc (ALLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALLO | BBOT | PHAT | ||
| Company | Allogene Therapeutics Inc | Bridgebio Oncology Therapeutics Inc | Phathom Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.13 | 9.07 | 8.51 | ||
| High | 2.14 | 9.46 | 9.19 | ||
| Low | 2.05 | 9.00 | 8.47 | ||
| Last | 2.07 | 9.42 | 9.17 | ||
| Change | -0.05 | +0.22 | +0.66 | ||
| Percent Change | -2.36% | +2.39% | +7.76% | ||
| Volume | 4,576,700 | 150,500 | 2,084,100 | ||
| 20-Day Average Volume | 5,906,760 | 262,610 | 1,688,810 | ||
| Previous | 2.12 | 9.20 | 8.51 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.88 | 8.74 | 10.02 | ||
| 20-Day Raw Stochastic | 79.31% | 88.13% | 23.82% | ||
| 20-Day Relative Strength | 54.63 | 58.92 | 42.48 | ||
| Weighted Alpha | +44.46 | -10.84 | -20.49 | ||
| Today's Opinion | 16% Sell | 8% Buy | 100% Sell | ||
| Yesterday's Opinion | Hold | 8% Sell | 100% Sell | ||
| Last Month's Opinion | 24% Sell | 40% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.15% since 08/05/26 | +5.13% since 08/05/26 | +11.42% since 08/05/26 | ||
| Low | 1.92 on 08/06/26 | 8.75 on 08/06/26 | 8.29 on 08/06/26 | ||
| High | 2.19 on 08/11/26 | 9.62 on 08/10/26 | 9.19 on 08/12/26 | ||
| 1-Month | |||||
| %Chg | +3.50% since 07/10/26 | +13.22% since 07/10/26 | -27.28% since 07/10/26 | ||
| Low | 1.61 on 07/28/26 | 7.93 on 07/17/26 | 8.21 on 08/05/26 | ||
| High | 2.19 on 08/11/26 | 9.62 on 08/10/26 | 12.64 on 07/13/26 | ||
| 3-Month | |||||
| %Chg | -10.00% since 05/12/26 | +15.87% since 05/12/26 | -26.82% since 05/12/26 | ||
| Low | 1.61 on 07/28/26 | 7.00 on 06/11/26 | 8.21 on 08/05/26 | ||
| High | 2.35 on 05/13/26 | 9.62 on 08/10/26 | 13.39 on 05/14/26 | ||
| 6-Month | |||||
| %Chg | +27.78% since 02/12/26 | -17.51% since 02/12/26 | -23.71% since 02/12/26 | ||
| Low | 1.61 on 07/28/26 | 7.00 on 06/11/26 | 8.21 on 08/05/26 | ||
| High | 4.46 on 04/13/26 | 11.73 on 02/13/26 | 14.39 on 02/26/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 731,729 | 736,984 | 688,468 | ||
| Shares Outstanding, K | 345,155 | 80,107 | 80,901 | ||
| Annual Sales, $M | 0 | 0 | 175,110,000 | ||
| Annual Net Income, $M | -190,890,000 | -134,040,000 | -221,250,000 | ||
| Last Qtr Sales, $M | 0 | 0 | 74,270,000 | ||
| Last Qtr Income, $M | -42,610,000 | -42,110,000 | -17,580,000 | ||
| 60-Month Beta | 0.48 | 0.36 | 0.51 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.18 on 05/13/26 | -0.48 on 05/12/26 | 0.00 on 07/30/26 | ||
| Latest Earnings Date | 08/12/26 | 08/11/26 | 10/29/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||